Back to search
FDAFDA · Food and drugs·Recall number F-1270-2013

ProtiDiet High Protein Chocolate Dream Bar

Published April 3, 2013 · Recall initiated: March 8, 2013

Summary

FDA records food Class I recall F-1270-2013, published April 3, 2013 and initiated March 8, 2013. Recalling firm: Doctors Best Weight Loss; Status: Terminated; Reported quantity: 3 boxes (21 bars in total); Lot: UPC 6 21498 42238 1, lot code CR 18 13B, and Best Before: 2015-08. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Recall was initiated after CFIA notified FDA of implicated products sold to the firm. During a FDA visit, the firm discovered that they were selling product that were recalled in Canada by the manufacturer, "Pro-Amino International Inc." because it may be contaminated with Salmonella. Upon further FDA investigation at the firm product was further distributed to a consignee in Canada.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Doctors Best Weight Loss
Distributor
Canada
Lot
UPC 6 21498 42238 1, lot code CR 18 13B, and Best Before: 2015-08.
Risk classification
Class I
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was ProtiDiet High Protein Chocolate Dream Bar recalled?

Yes. FDA published recall F-1270-2013 on April 3, 2013. Reported hazard: Recall was initiated after CFIA notified FDA of implicated products sold to the firm. During a FDA visit, the firm discovered that they were selling product that were recalled in Canada by the manufacturer, "Pro-Amino International Inc." because it may be contaminated with Salmonella. Upon further FDA investigation at the firm product was further distributed to a consignee in Canada.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit